Eagle Asset Management’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-264,624
Closed -$19.3M 630
2021
Q4
$19.3M Sell
264,624
-19,940
-7% -$1.64M 0.08% 220
2021
Q3
$25.9M Buy
+284,564
New +$24.2M 0.12% 197
2021
Q2
Sell
-149,169
Closed -$4.17M 618
2021
Q1
$4.17M Buy
+149,169
New +$3.59M 0.02% 423

Other funds holding ASTH

Eagle Asset Management's ASTH Position: Q1 2022 in Review

Eagle Asset Management sold out of Astrana Health (ASTH) in Q1 2022, closing a stake of 264,624 shares — an estimated $19.3M sold.

Eagle Asset Management first reported a position in ASTH in Q1 2021 and held it in 3 quarters. The position peaked at $25.9M in Q3 2021. 139 funds tracked by Wall St. Rank hold ASTH as of Q1 2022.

  • Eagle Asset Management reported no remaining Astrana Health position as of Q1 2022 after selling out during the quarter.
  • Eagle Asset Management sold 264,624 Astrana Health shares in Q1 2022, an estimated $19.3M.
  • Eagle Asset Management first reported a position in Astrana Health in Q1 2021 and held it in 3 quarters.
  • Eagle Asset Management's Astrana Health position peaked at $25.9M in Q3 2021.
  • 139 funds tracked by Wall St. Rank held Astrana Health as of Q1 2022.

Based on Eagle Asset Management's 13F filing for Q1 2022, filed 12 May 2022.